The Athena wearable uses scalp cooling to reduce hair loss in chemotherapy patients and ... which is circulated around the ...
Reported positive YTD 2024 Adjusted EBITDA of $1.4 million Company expects Q4 2024 Net Revenue in the range of $37 million - $43 million ZYNRELEF® (bupivacaine ...
Science Losing hair during chemotherapy is no longer inevitable. An innovative helmet could soon improve the comfort of ...
Oncology nurses Kate Shady, Ph.D., RN, OCN, and Krystle Becraft, BSN, RN, OCN, saw an opportunity to improve the safety of patients with central venous catheters (CVCs), commonly known as “central ...
UPMC Home Healthcare of Central Pennsylvania and Family Hospice are calling on the community to help honor local veterans ...